Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 22.68%, near the low end of its 5-year range (0.00%–68.07%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
0.00%
DEBT TO ASSETS RATIO AVG 3Y
24.33%
DEBT TO ASSETS RATIO AVG 5Y
22.68%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 458 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Alpha Cognition Inc
Market Cap
$142.11M
Debt to Assets Ratio
0.00%
TTM Avg
0.00%
3Y Avg
24.33%
5Y Avg
22.68%
Market Cap
$142.49M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$146.66M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$134.74M
Debt to Assets Ratio
0.36%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$152.16M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$152.45M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$153.84M
Debt to Assets Ratio
0.27%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Cognition Inc (ACOG) | $142.11M | 0.00% | 0.00% | 24.33% | 22.68% |
| Fortress Biotech, Inc. (FBIOP)vs › | $142.49M | 0.20% | N/A | N/A | N/A |
| Immuneering Corporation (IMRX)vs › | $146.66M | 0.02% | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $137.29M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $134.74M | 0.36% | N/A | N/A | N/A |
| Codexis, Inc. (CDXS)vs › | $149.51M | 0.60% | N/A | N/A | N/A |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.16M | 0.00% | N/A | N/A | N/A |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.45M | 0.00% | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $153.84M | 0.27% | N/A | N/A | N/A |
| Health Catalyst, Inc. (HCAT)vs › | $130.05M | 0.47% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
9.03
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 1.80% |
| 2024-09-30 | 44.04% |
| 2024-06-30 | 58.19% |
| 2024-03-31 | 34.85% |
| 2023-12-31 | 49.77% |
| 2023-09-30 | 68.07% |
| 2023-06-30 | 59.52% |
| 2023-03-31 | 25.22% |
| 2022-12-31 | 41.05% |
| 2022-09-30 | 26.32% |
| 2022-06-30 | 16.68% |
| 2022-03-31 | 10.37% |
| 2021-12-31 | 8.35% |
| 2021-09-30 | 16.41% |
| 2021-06-30 | 15.75% |
| 2021-03-31 | 11.97% |
| 2021-01-31 | 38.11% |
